Isoptin: Advanced Calcium Channel Blocker for Hypertension & Angina Control
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.34 | $40.07 (0%) | 🛒 Add to cart |
| 60 | $0.95 | $80.13 $57.10 (29%) | 🛒 Add to cart |
| 90 | $0.83 | $120.20 $75.13 (38%) | 🛒 Add to cart |
| 120 | $0.78 | $160.27 $93.16 (42%) | 🛒 Add to cart |
| 180 | $0.71 | $240.40 $127.21 (47%) | 🛒 Add to cart |
| 270 | $0.66 | $360.61 $179.30 (50%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $480.81 $232.39 (52%) | 🛒 Add to cart |
| Product dosage: 240mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.74 | $52.09 (0%) | 🛒 Add to cart |
| 60 | $1.30 | $104.18 $78.13 (25%) | 🛒 Add to cart |
| 90 | $1.17 | $156.26 $105.18 (33%) | 🛒 Add to cart |
| 120 | $1.09 | $208.35 $130.22 (37%) | 🛒 Add to cart |
| 180 | $1.01 | $312.53 $182.31 (42%) | 🛒 Add to cart |
| 270 | $0.97 | $468.79 $262.44 (44%) | 🛒 Add to cart |
| 360 | $0.94
Best per pill | $625.05 $338.57 (46%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.07 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $64.61 $53.09 (18%) | 🛒 Add to cart |
| 120 | $0.52 | $86.14 $62.10 (28%) | 🛒 Add to cart |
| 180 | $0.46 | $129.22 $82.14 (36%) | 🛒 Add to cart |
| 270 | $0.41 | $193.83 $110.19 (43%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $258.43 $139.23 (46%) | 🛒 Add to cart |
Isoptin, known generically as verapamil hydrochloride, is a trusted calcium channel blocker medication prescribed for the management of hypertension (high blood pressure), chronic stable angina, and certain heart rhythm disorders. By inhibiting calcium influx into vascular smooth muscle and cardiac cells, it effectively reduces peripheral vascular resistance and myocardial oxygen demand, promoting cardiovascular stability and symptom relief. This medication is available in various formulations, including immediate-release and extended-release tablets, to accommodate individualized treatment plans under strict medical supervision.
Features
- Active ingredient: Verapamil hydrochloride
- Available in immediate-release (IR) and extended-release (ER) formulations
- Tablet strengths ranging from 40 mg to 240 mg
- Prescription-only medication requiring healthcare provider authorization
- Manufactured under strict pharmaceutical quality control standards
- Suitable for long-term cardiovascular management
Benefits
- Effectively lowers high blood pressure, reducing the risk of stroke, heart attack, and kidney damage
- Decreases frequency and severity of angina pectoris episodes, improving exercise tolerance
- Helps control certain abnormal heart rhythms (e.g., atrial fibrillation, supraventricular tachycardia)
- May be used as monotherapy or in combination with other antihypertensive agents
- Extended-release formulation allows for convenient once-daily dosing in appropriate patients
- Well-established safety profile with decades of clinical use and research
Common use
Isoptin (verapamil) is primarily indicated for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive medications. It is also approved for the treatment of chronic stable angina pectoris when beta-blockers are contraindicated or ineffective. Additionally, it is used in certain arrhythmia management protocols, particularly for controlling ventricular rate in atrial fibrillation and flutter, and for preventing paroxysmal supraventricular tachycardia episodes. Off-label uses may include migraine prophylaxis, hypertrophic cardiomyopathy management, and Raynaud’s phenomenon treatment, though these applications require specialized medical evaluation.
Dosage and direction
Dosage must be individualized based on the patient’s clinical condition, response to therapy, and formulation prescribed. For hypertension: Initial dose typically ranges from 80-120 mg three times daily for immediate-release or 180-240 mg once daily for extended-release formulations, with adjustments made at weekly intervals. Maximum daily dose should not exceed 480 mg in divided doses. For angina: Starting dose is usually 80-120 mg three times daily, titrated upward until optimal response is achieved. For arrhythmias: Dosage varies significantly based on the specific condition, typically ranging from 240-480 mg daily in divided doses. Tablets should be swallowed whole with a glass of water, with or without food consistently. Extended-release tablets must not be crushed, chewed, or divided. Regular blood pressure monitoring and clinical assessment are essential during dosage titration.
Precautions
Patients should undergo comprehensive cardiovascular assessment before initiating therapy. Regular monitoring of blood pressure, heart rate, ECG, and liver function is recommended during treatment. Use with caution in patients with impaired hepatic function, as dosage adjustments may be necessary. May mask hypoglycemia symptoms in diabetic patients. Gradual withdrawal is recommended to avoid rebound hypertension or angina exacerbation. Patients should avoid sudden position changes to minimize orthostatic hypotension risk. Not recommended during pregnancy unless potential benefits outweigh risks. Breastfeeding should be discontinued during therapy. Elderly patients may require lower initial doses due to decreased hepatic and renal function. Patients should inform healthcare providers about all medications being taken, including over-the-counter products and supplements.
Contraindications
Isoptin is contraindicated in patients with known hypersensitivity to verapamil or any component of the formulation. Additional contraindications include: severe left ventricular dysfunction, hypotension (systolic pressure <90 mmHg), sick sinus syndrome or second- or third-degree AV block (except in patients with a functioning artificial pacemaker), atrial flutter or fibrillation with accessory bypass tracts (e.g., WPW or LGL syndromes), and cardiogenic shock. Concurrent use with ivabradine is contraindicated. Should not be administered with beta-blockers in patients with significant ventricular dysfunction or conduction abnormalities. Contraindicated in patients with severe hepatic impairment.
Possible side effect
Common side effects (≥1%) may include constipation, dizziness, nausea, hypotension, headache, edema, fatigue, and bradycardia. Less frequent adverse reactions include flushing, dyspnea, rash, elevated liver enzymes, and gingival hyperplasia. Serious side effects requiring immediate medical attention include: symptomatic bradycardia, heart failure exacerbation, severe hypotension, hepatotoxicity, and severe skin reactions. Constipation may be managed with appropriate dietary measures or laxatives under medical guidance. Most side effects are dose-dependent and may diminish with continued therapy or dosage adjustment. Patients should report any persistent or severe symptoms to their healthcare provider promptly.
Drug interaction
Isoptin has numerous significant drug interactions due to its metabolism via CYP3A4 and P-glycoprotein inhibition. Concomitant use with beta-blockers may potentiate bradycardia and AV conduction disturbances. May increase digoxin levels by 50-75%, requiring dosage adjustment and monitoring. Enhances effects of other antihypertensive agents, potentially causing excessive hypotension. CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, ritonavir) significantly increase verapamil concentrations. May reduce clearance and increase toxicity of certain statins, cyclosporine, tacrolimus, and carbamazepine. Concurrent use with disopyramide or flecainide within 48 hours may cause excessive myocardial depression. Potentiates neuromuscular blocking agents’ effects. St John’s Wort may decrease verapamil efficacy. Alcohol may enhance hypotensive and sedative effects.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should never double the dose to make up for a missed one, as this may increase the risk of adverse effects. For extended-release formulations, maintaining consistent 24-hour intervals is particularly important. If multiple doses are missed or uncertainty exists about proper management, patients should consult their healthcare provider or pharmacist for guidance. Consistent adherence to the prescribed regimen is crucial for optimal therapeutic outcomes.
Overdose
Verapamil overdose can be life-threatening, primarily manifesting as severe hypotension, bradycardia, and conduction abnormalities. Other symptoms may include confusion, drowsiness, nausea, vomiting, metabolic acidosis, hyperglycemia, and non-cardiogenic pulmonary edema. Management requires immediate medical attention with continuous cardiac and blood pressure monitoring. Treatment is supportive and may include intravenous calcium gluconate or chloride, vasopressors, atropine for bradycardia, and intravenous fluids. Glucagon may be beneficial in some cases. In severe cases, cardiac pacing, inotropic support, or intravenous lipid emulsion therapy may be necessary. Gastric lavage may be considered if presentation is early. Hemodialysis is not effective due to high protein binding and extensive tissue distribution.
Storage
Store at controlled room temperature (20-25°C or 68-77°F), protecting from light and moisture. Keep in the original container with the lid tightly closed. Do not store in bathroom cabinets where humidity may affect stability. Keep all medications out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly discard any unused or expired medication through take-back programs or following specific disposal instructions to prevent accidental ingestion or environmental contamination. Do not flush medications down the toilet unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Isoptin is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to therapy may vary, and treatment decisions should be based on comprehensive medical evaluation. Patients should not alter their dosage or discontinue treatment without consulting their healthcare provider. The manufacturer and distributors are not liable for any consequences arising from the use or misuse of this information. Always refer to the official prescribing information for complete details.
Reviews
Clinical studies and patient reports consistently demonstrate Isoptin’s effectiveness in blood pressure control and angina management. Many patients experience significant improvement in exercise tolerance and quality of life. Healthcare professionals appreciate its well-characterized pharmacokinetics and multiple formulation options that allow for treatment individualization. Some patients report constipation as a manageable side effect with proper dietary adjustments. The extended-release formulation receives particular praise for its convenience and stable 24-hour coverage. Overall, Isoptin remains a valued option in cardiovascular therapeutics, with decades of clinical experience supporting its appropriate use in properly selected patients under medical supervision.